Skip to main content

Table 1 Description of visits

From: Personalized at-home neurofeedback compared with long-acting methylphenidate in an european non-inferiority randomized trial in children with ADHD

Visit

Pre-inclusion

Inclusion

Discovery or open titration

Treatment period (MPH or NFB)

Initial discovery or titration

Discovery or titration

Discovery or titration

Final discovery or titration

Intermediate

Final

Day

D-90 to D-1

D0

D7 ± 3

D14 ± 3

D21 ± 3

D28 ± 3

D60 ± 7

D90 ± 10

Protocol explanation

X

       

Inform consent form

 

X

      

Inclusion/exclusion criteria

 

X

      

Demographic data

 

X

      

Medical/surgical history

 

X

      

Medical examination

 

X

      

qEEG

 

X

    

X

X

Randomisation

 

X

      

MPH delivery

  

X

X

X

X

X

 

NFB discovery session

  

X

X

X

X

X

 

Kiddie-Sads

X

       

ADHD RS parents

 

X

    

X

X

ADHD RS clinician

 

X

    

X

X

ADHD RS teacher

 

X

     

X

CGI-I score

  

X

X

X

X

X

X

CGI-S score

 

X

X

X

X

X

X

X

C-SSRS (Columbia suicide rating scale

 

X

X

X

X

X

X

X

SDSC

 

X

X

X

X

X

X

X

SDQ by teacher/parent

 

X

     

X

BRIEF

 

X

     

X

Conners 3 CPT

 

X

     

X

WASI 3 subtest (or WISC less 3 months)

X

       

Concomitant treatments

 

X

X

X

X

X

X

X

Adverse event collection (spontaneous)

  

X

X

X

X

X

X

PAERS questionnaire

 

X

X

X

X

X

X

X

Back to article page

BMC Psychiatry

ISSN: 1471-244X

Contact us